It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

Discover why CVS Health Corporation is a top S&P 500 performer in 2025. See bullish forecasts, strong growth, and a new price ...

Dec 9 (Reuters) - CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, ...

CVS Health Corp. raised its full-year profit forecast and said earnings would rise in 2026, a sign of hope as it navigates a ...

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

A Florida judge on Monday declared a mistrial in a lawsuit that accused Walmart, CVS and Walgreens of flooding the state with ...

The healthcare company says it expects to post a narrower per-share loss in 2025.

CVS Health’s stock rose more than 2% on Tuesday after the company boosted its revenue and profit guidance for the year and ...

In addition to the updates for 2025, CVS offered its first look at expected earnings for 2026. The company said it ...

Jim Cramer says he salutes CVS chief executive David Joyner. His remarks arrive after CVS raised its profit guidance for 2026 ...